Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
H. pylori Eradication for Motor Fluctuations in Parkinson's Disease
NCT00664209Phase 3Terminated
- Sponsor
- University of California, Los Angeles
- Start
- Jan 2008
- Primary completion
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of clarithromycin, amoxicillin, omeprazole in Parkinson's disease (PD), sponsored by University of California, Los Angeles. Started Jan 2008; status: terminated.
02
Drugs
clarithromycinamoxicillinomeprazole
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00664209.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00664209.